share_log

Invivyd | DEF 14A: Definitive information statements

Invivyd | DEF 14A: Definitive information statements

Invivyd | DEF 14A：股东委托书决议
美股sec公告 ·  04/18 16:11
Moomoo AI 已提取核心信息
Invivyd, Inc., a biotechnology company, has scheduled its 2024 Annual Meeting of Stockholders to be held virtually on May 21, 2024. The meeting will address the election of seven director nominees, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and other business matters. The Board recommends voting FOR ALL director nominees and FOR the ratification of PricewaterhouseCoopers LLP. Proxy materials will be mailed to stockholders around April 18, 2024, and will include instructions on how to vote and access the Proxy Statement and the 2023 Annual Report on Form 10-K. The record date for determining stockholders eligible to vote at the meeting is March 22, 2024. The meeting will be accessible online, with no in-person attendance option, and stockholders will be able to submit questions and vote during the live webcast.
Invivyd, Inc., a biotechnology company, has scheduled its 2024 Annual Meeting of Stockholders to be held virtually on May 21, 2024. The meeting will address the election of seven director nominees, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and other business matters. The Board recommends voting FOR ALL director nominees and FOR the ratification of PricewaterhouseCoopers LLP. Proxy materials will be mailed to stockholders around April 18, 2024, and will include instructions on how to vote and access the Proxy Statement and the 2023 Annual Report on Form 10-K. The record date for determining stockholders eligible to vote at the meeting is March 22, 2024. The meeting will be accessible online, with no in-person attendance option, and stockholders will be able to submit questions and vote during the live webcast.
生物技术公司Invivyd, Inc. 计划于2024年5月21日以虚拟方式举行其2024年年度股东大会。会议将讨论七名董事候选人的选举、批准普华永道会计师事务所为截至2024年12月31日的财政年度的独立注册会计师事务所以及其他业务事项。董事会建议对所有董事候选人进行投票，并支持批准普华永道会计师事务所。代理材料将在2024年4月18日左右邮寄给股东，其中包括有关如何投票和访问委托书以及10-K表2023年年度报告的说明。确定有资格在会议上投票的股东的记录日期是2024年3月22日。会议将可在线访问，没有亲自出席的选项，股东将能够在网络直播期间提交问题和投票。
生物技术公司Invivyd, Inc. 计划于2024年5月21日以虚拟方式举行其2024年年度股东大会。会议将讨论七名董事候选人的选举、批准普华永道会计师事务所为截至2024年12月31日的财政年度的独立注册会计师事务所以及其他业务事项。董事会建议对所有董事候选人进行投票，并支持批准普华永道会计师事务所。代理材料将在2024年4月18日左右邮寄给股东，其中包括有关如何投票和访问委托书以及10-K表2023年年度报告的说明。确定有资格在会议上投票的股东的记录日期是2024年3月22日。会议将可在线访问，没有亲自出席的选项，股东将能够在网络直播期间提交问题和投票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息